Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,435 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Completed

Study to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

NCT02968563

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Ambulante Krebszentrum Schaubstraße Frankfurt (Oder), Brandenburg, Germany
  • Hämatologische-onkologische Gem.-Praxis Dres. Brudler-Heinrich-Bangerter, Augsburg Augsburg, Germany
  • Uniklinik Koln Cologne, Germany
  • Internistische Gemeinschaftspraxis Dres. Schliesser-Käbisch-Weber, Gießen Giessen, Germany
View all 14 locations
View Trial Details
Completed

A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting

NCT03720561

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Ospedali Riuniti Di Ancona Ancona, Italy
  • U.O.C. Ematologia e Terapia Cellulare Ospedale C e G Mazzoni Ascoli Piceno, Italy
  • U.O. Ematologia con Trapianto- AOU Policlinico di Bari Bari, Italy
  • U.O. Ematologia Istituto Tumori Giovanni Paolo II Bari, Italy
View all 39 locations
View Trial Details
Completed

Safety and Efficacy of the Combination of Tirabrutinib and Entospletinib With and Without Obinutuzumab in Adults With Chronic Lymphocytic Leukemia (CLL)

NCT02983617

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Studienzentrum Aschaffenburg Aschaffenburg, Germany
  • Evangelisches Diakoniekrankenhaus Bremen Hämatologie Bremen, Germany
  • Uniklinik Köln Klinik I für Innere Medizin Cologne, Germany
  • St.-Johannes-Hospital Dortmund, Germany
View all 15 locations
View Trial Details
Completed

Study to Evaluate Safety and Preliminary Efficacy of Tafasitamab With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi

NCT02639910

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Clinical Study Site Jacksonville, Florida, United States
  • Clinical Study Site Rochester, Minnesota, United States
  • Clinical Study Site Columbus, Ohio, United States
  • Clinical Study Site Graz, Austria
View all 17 locations
View Trial Details
Completed

A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion

NCT01889186

Conditions
17p Deletion, Cancer of the Blood and Bone Marrow, Chromosome 17 deletion, +17 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 96748 Tucson, Arizona, United States
  • City of Hope /ID# 112875 Duarte, California, United States
  • Moore UC San Diego Cancer Center /ID# 91793 La Jolla, California, United States
  • Stanford University School of Med /ID# 105117 Stanford, California, United States
View all 48 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

NCT00774345

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +14 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • Pacific Coast Hematology Oncology Fountain Valley, California, United States
  • Kaiser Permanente Medical Group San Diego, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 241 locations
View Trial Details

Related conditions